Neeraj Kumar

Neeraj Kumar

Auto-generated profile, based on publicly available information

Neeraj Kumar

Department of Pharmacology, School of Pharmaceutical Sciences, Shri Guru Ram Rai University,Dehradun-248001, Uttarakhand, India

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 February 2024 in Oriental Journal of Chemistry
Verified
Journal Article
Open access
PDF file
SUSushmita Uniyal
Sushmita Uniyal
NKNeeraj Kumar
Neeraj Kumar
BJBhuwan Joshi
Bhuwan Joshi
Many diseases are associated with free radicals and oxidative stress, which result from reactive oxygen and nitrogen species. These high ROS levels affect various metabolic and signalling mechanisms leading to changes in physiological processes and the emergence of illnesses like cancer. In addition to dietary, mammalian cells have natural ROS scavenging mechanisms that includes enzymatic and non-enzymatic antioxidants. This review discuss the free radicals with relation to cancer development, as well as the role of antioxidants in the immune defence mechanism against free radicals. The review also explores various approaches for manipulating antioxidants and free radicals in the prevention and management of cancer, such as gene therapy, genetically engineered plants with higher antioxidant levels, artificial antioxidant enzymes, novel biomolecules, and antioxidant-rich foods. Future applications of these approaches are also discussed.

1 June 2026 in Recent Patents on Biotechnology
Verified
Journal Article
Closed access
SSSushmita Semwal
Sushmita Semwal
NKNeeraj Kumar
Neeraj Kumar
BJBhuwan Joshi
Bhuwan Joshi
Piyush VermaPiyush Verma
Piyush Verma
Background: The plant Cinnamomum tamala (Buch.-Ham.) T. Nees & C.H. Ebern. (Family: Lauraceae) is commonly known as ‘tejpaat’ in India, has leaves and bark reported to possess anticancer, immunomodulatory, antidiabetic, and diuretic activities. The objective of the present study was to explore the antitumor potential of the chloroform extract of Cinnamomum tamala leaves (CTCE) in BALB/c mice against Ehrlich’s Carcinoma (EC). Methods: Based on preliminary in-vitro cytotoxicity studies, CTCE was selected for an in-vivo antitumor study. Anticancer activity of CTCE was evaluated in BALB/c mice against EC at the doses of 50, 100, 250, and 500 mg/kg body weight. CTCE was administered for 15 consecutive days after induction of the tumor. After 24 hours from the last administered dose and 18 hours of fasting, half of the mice were sacrificed, while the other half was kept alive to evaluate any potential for increasing the lifespan. The antitumor effect of CTCE was assessed by evaluating tumor volume, hematological parameters, and the life span of the EC-bearing host. Results: CTCE showed a significant decrease (p<0.05) in tumor volume and increased the lifespan of EC tumor-bearing mice in a dose-dependent manner compared with the untreated group. The hematological profile, including RBC count, hemoglobin, WBC count, and DLC, was also improved upon treatment. Discussion: C. tamala chloroform extract (CTCE) showed significant anticancer potential by reducing cell viability, inhibiting tumor growth, and prolonging survival without toxicity, suggesting it as a promising source of bioactive compounds for anticancer drug development. Conclusion: The results suggest that CTCE exhibits dose-dependent anticancer activity in comparison with EC control mice and demonstrates significant effects relative to doxorubicin. Its antitumor activity may be attributed to the presence of active constituents within the extract. This investigation also highlights recent advancements in intellectual property rights and patent strategies related to plant-derived anticancer agents.

31 December 2025 in Journal of Natural Remedies
Verified
Journal Article
Open access
NKNeeraj Kumar
Neeraj Kumar
MOMonika
Monika
Background: Diabetes mellitus is a worldwide health problem that needs new therapeutics with multimodal action. Premna barbata has been conventionally used for its medicinal value, but its antidiabetic efficacy needs scientific authentication. Aim: The present study scientifically assesses the antidiabetic and antihyperlipidemic efficacy of Premna barbata stem bark extract in a streptozotocin (STZ)-nicotinamide (NA)-induced diabetic albino Wistar rat model. Methods: Type 2 diabetes was induced in rats through intraperitoneal administration of STZ (55-65 mg/kg) following NA pre-treatment. Rats were assigned to a normal control, diabetic control, PBSB-treated (200, 400, 800 mg/kg orally), and positive control (gliclazide) groups. Blood glucose, body weight, lipid profiles (total cholesterol, triglycerides), and oxidative stress markers (SOD, CAT, MDA) were measured every week for 28 days. Results: Data revealed dose-dependent glucose-lowering activities, lowering blood glucose levels significantly like gliclazide. The extract was found to possess strong antihyperlipidemic activity, with the highest dose significantly decreasing total cholesterol and reducing triglycerides moderately. Diabetic rats gained weight and underwent oxidative stress. PBSB increased peripheral glucose utilisation, optimised oral glucose tolerance, and reversed STZ-induced β-cell apoptosis. Conclusion: Premna barbata stem bark extract possesses strong antidiabetic and antihyperlipidaemic activities through various mechanisms such as improved glucose tolerance, modulation of lipids, and inhibition of oxidative stress. This validates its possibility as a useful complementary drug for diabetes and related metabolic disturbances. Major Findings: Results show successful inhibition of diabetic hyperglycaemia and dyslipidemia in rats in a dose-related manner similar to reference drugs. The extract reversed diabetic weight loss and markers of oxidative stress, underscoring its therapeutic potential and affirming the traditional uses of Premna barbata in the control of diabetes.